363 related articles for article (PubMed ID: 27983931)
1. Fibroblast Activation Protein-α-Positive Fibroblasts Promote Gastric Cancer Progression and Resistance to Immune Checkpoint Blockade.
Wen X; He X; Jiao F; Wang C; Sun Y; Ren X; Li Q
Oncol Res; 2017 Apr; 25(4):629-640. PubMed ID: 27983931
[TBL] [Abstract][Full Text] [Related]
2. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
[TBL] [Abstract][Full Text] [Related]
3. Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ β-catenin pathway.
Liu J; Huang C; Peng C; Xu F; Li Y; Yutaka Y; Xiong B; Yang X
BMC Cancer; 2018 Nov; 18(1):1099. PubMed ID: 30419872
[TBL] [Abstract][Full Text] [Related]
4. FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC.
Liu J; Ouyang Y; Xia Z; Mai W; Song H; Zhou F; Shen L; Chen K; Li X; Zhuang SM; Liao J
Cell Oncol (Dordr); 2024 Apr; 47(2):623-638. PubMed ID: 37856075
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein.
Gallant JP; Hintz HM; Gunaratne GS; Breneman MT; Recchia EE; West JL; Ott KL; Heninger E; Jackson AE; Luo NY; Rosenkrans ZT; Hernandez R; Zhao SG; Lang JM; Meimetis L; Kosoff D; LeBeau AM
Cancer Res Commun; 2024 Jun; 4(6):1481-1494. PubMed ID: 38747612
[TBL] [Abstract][Full Text] [Related]
6. FAP positive fibroblasts induce immune checkpoint blockade resistance in colorectal cancer via promoting immunosuppression.
Chen L; Qiu X; Wang X; He J
Biochem Biophys Res Commun; 2017 May; 487(1):8-14. PubMed ID: 28302482
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers in Tumor Microenvironment? Upregulation of Fibroblast Activation Protein-α Correlates with Gastric Cancer Progression and Poor Prognosis.
Hu M; Qian C; Hu Z; Fei B; Zhou H
OMICS; 2017 Jan; 21(1):38-44. PubMed ID: 28206814
[TBL] [Abstract][Full Text] [Related]
9. Roles of Fibroblast Activation Protein and Hepatocyte Growth Factor Expressions in Angiogenesis and Metastasis of Gastric Cancer.
Gao LM; Wang F; Zheng Y; Fu ZZ; Zheng L; Chen LL
Pathol Oncol Res; 2019 Jan; 25(1):369-376. PubMed ID: 29134462
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K
BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
Kakarla S; Chow KK; Mata M; Shaffer DR; Song XT; Wu MF; Liu H; Wang LL; Rowley DR; Pfizenmaier K; Gottschalk S
Mol Ther; 2013 Aug; 21(8):1611-20. PubMed ID: 23732988
[TBL] [Abstract][Full Text] [Related]
12. RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis.
Brünker P; Wartha K; Friess T; Grau-Richards S; Waldhauer I; Koller CF; Weiser B; Majety M; Runza V; Niu H; Packman K; Feng N; Daouti S; Hosse RJ; Mössner E; Weber TG; Herting F; Scheuer W; Sade H; Shao C; Liu B; Wang P; Xu G; Vega-Harring S; Klein C; Bosslet K; Umaña P
Mol Cancer Ther; 2016 May; 15(5):946-57. PubMed ID: 27037412
[TBL] [Abstract][Full Text] [Related]
13. Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma.
Watanabe S; Noma K; Ohara T; Kashima H; Sato H; Kato T; Urano S; Katsube R; Hashimoto Y; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
Cancer Biol Ther; 2019; 20(9):1234-1248. PubMed ID: 31185791
[TBL] [Abstract][Full Text] [Related]
14. Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment.
Lin Y; Li B; Yang X; Cai Q; Liu W; Tian M; Luo H; Yin W; Song Y; Shi Y; He R
Neoplasia; 2019 Dec; 21(12):1133-1142. PubMed ID: 31759251
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway.
Zi FM; He JS; Li Y; Wu C; Wu WJ; Yang Y; Wang LJ; He DH; Yang L; Zhao Y; Zheng GF; Han XY; Huang H; Yi Q; Cai Z
Cancer Biol Ther; 2014 Oct; 15(10):1413-22. PubMed ID: 25046247
[TBL] [Abstract][Full Text] [Related]
16. Polyphyllin I inhibits gastric cancer cell proliferation by downregulating the expression of fibroblast activation protein alpha (FAP) and hepatocyte growth factor (HGF) in cancer-associated fibroblasts.
Dong R; Guo J; Zhang Z; Zhou Y; Hua Y
Biochem Biophys Res Commun; 2018 Mar; 497(4):1129-1134. PubMed ID: 29499193
[TBL] [Abstract][Full Text] [Related]
17. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.
LeBeau AM; Brennen WN; Aggarwal S; Denmeade SR
Mol Cancer Ther; 2009 May; 8(5):1378-86. PubMed ID: 19417147
[TBL] [Abstract][Full Text] [Related]
18. Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma.
Gunderson AJ; Yamazaki T; McCarty K; Phillips M; Alice A; Bambina S; Zebertavage L; Friedman D; Cottam B; Newell P; Gough MJ; Crittenden MR; Van der Veken P; Young KH
PLoS One; 2019; 14(2):e0211117. PubMed ID: 30726287
[TBL] [Abstract][Full Text] [Related]
19. MiR-30a suppresses metastasis of gastric adenocarcinoma via targeting FAPα.
Yu T; Gong L; Li W; Zuo Q; Cai D; Mao H; Wang L; Lin J; Xiao B
Cancer Biomark; 2020; 27(4):471-484. PubMed ID: 32116236
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
